For treatment of: Novo-Passit, migraine, neurasthenia, insomnia, menopause, increased resistance to stress, increased irritability, irritable bowel syndrome.Novo-Passit Sedatives
- For the treatment of internal organs: nervous system.
- Appointment: migraine, neurasthenia, insomnia, menopause, increased resistance to stress, increased irritability, irritable bowel syndrome.
- Indications for use:
Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, distraction. “Manager's syndrome” (a state of constant mental stress) Insomnia (mild forms).
Headaches caused by nervous tension.
Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome). As a symptomatic treatment for neurocirculatory dystonia and menopausal syndrome. Itchy dermatoses (eczema atopic and seborrheic, urticaria), due to psychological stress.
Hypersensitivity to the components of the drug, especially to guaifenesin, myasthenia gravis children under 12 years of age.
Novo-Passita dry extract (obtained from rhizomes with roots of Valerian officinalis, herb Melissa officinalis, herb St. John's wort holed* leaves and flowers of hawthorn odnopestichny or prickly, grass passionflower incarnate (passion flower), coplodium of ordinary hops, black elderberry flowers) 157.5 mg; guaifenesin 200.0 mg
Silicon dioxide colloidal 2.0 mg, microcrystalline cellulose 96.0 mg, glycerol 10.0 mg, magnesium stearate 10.0 mg, lactose monohydrate up to 800.0 mg Shell:
Opadray “AMV 80W31115” green (polyvinyl alcohol 45.52 %, titanium dioxide 26.5 %, talc 20.0 %, soy lecithin 2.0 %, xanthan gum 0.48 %, dye : quinoline yellow 2.5 %, yellow iron oxide 2.0 %, dye indigocarmine 1.0 %) 24.0 mg.
- Manufacturer: Teva